Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 8,391	$ (7,263)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	10,469	10,467
Deferred income taxes and related valuation allowance	1,272	(245)
Net loss (gain) on sale of real estate, investments and other	485	(391)
Stock-based compensation	751	2,262
Amortization of deferred financing costs	430	471
Gain (Loss) on Extinguishment of Debt	0	14,803
Unrealized Gain (Loss) on Derivatives	(192)	0
Gain (Loss) on Disposition of Assets	173	0
Other Operating Activities, Cash Flow Statement	2,139	1,989
Changes in operating assets and liabilities, net of effects of business acquisitions:
Trade accounts receivable	11,265	2,043
Inventories	(21,467)	(10,802)
Prepaid expenses and other	359	(5,714)
Increase (Decrease) in Other Operating Assets	(143)	35
Trade accounts payable	(15,720)	(5,879)
Increase (Decrease) in Accrued Liabilities	(6,938)	(5,945)
Increase (Decrease) in Other Noncurrent Liabilities	(2,451)	(3,227)
Net cash provided by (used for) operating activities	(11,177)	(7,396)
INVESTING ACTIVITIES:
Proceeds from Sale and Maturity of Marketable Securities	650	2,181
Payments to Acquire Marketable Securities	(1,226)	(4,137)
Payments to Acquire Property, Plant, and Equipment	(2,953)	(3,648)
Proceeds from Equity Method Investment, Distribution, Return of Capital	313	0
Proceeds from Insurance Settlement, Investing Activities	0	482
Payments to Acquire Businesses, Net of Cash Acquired	(1,616)	(475,311)
Net cash provided by (used for) investing activities	(4,832)	(480,433)
FINANCING ACTIVITIES:
Proceeds from the issuance of common stock	415	290
Repayment of debt	(10,128)	(455,040)
Proceeds from Issuance of Long-term Debt	0	650,000
Proceeds from Issuance or Sale of Equity	0	207,000
Stock Issued During Period, Value, Stock Options Exercised	0	(25,292)
Proceeds from Derivative Instrument, Financing Activities	6,163	0
Payments for Derivative Instrument, Financing Activities	(6,022)	0
Payments of Dividends	(1,996)	(1,439)
Other	(1,313)	(1,764)
Net cash provided by (used for) financing activities	(12,881)	373,755
Effect of exchange rate changes on cash	(840)	601
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(29,730)	(113,473)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance	85,910	88,904
Supplementary cash flow data:
Interest Paid, Excluding Capitalized Interest, Operating Activities	5,741	4,398
Income taxes paid, net of refunds	3,940	1,164
Capital Expenditures Incurred but Not yet Paid	204	1,095
Restricted Cash	$ 250	$ 250